Try the Demo today!
| SEC Filing | Insider | Company | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Return |
|---|---|---|---|---|---|---|---|---|---|
| 25-Jan-24 6:03 AM View:  | Wood Barbara A EVP, Gen. Counsel, Corp. Sec. | Galena Biopharma, Inc. (SLS) | 22-Jan-24 | Grant | 35,000 | -- | -- | 43% 82.22K to 117.22K | |
| 25-Jan-24 6:03 AM View: | Scheinberg David A Director | Galena Biopharma, Inc. (SLS) | 22-Jan-24 | Grant | 6,000 | -- | -- | 131% 4.58K to 10.58K | |
| 25-Jan-24 6:02 AM View: | Francomano Robert Chief Commercial Officer | Galena Biopharma, Inc. (SLS) | 22-Jan-24 | Grant | 20,000 | -- | -- | 96% 20.92K to 40.92K | |
| 25-Jan-24 6:03 AM View: | Kalin Katherine Bach Director | Galena Biopharma, Inc. (SLS) | 22-Jan-24 | Grant | 6,000 | -- | -- | 240% 2.5K to 8.5K | |
| 25-Jan-24 6:04 AM View: | Stergiou Andelos M. President and CEO Director | Galena Biopharma, Inc. (SLS) | 22-Jan-24 | Grant | 159,000 | -- | -- | 73% 217.42K to 376.42K | |
| 25-Jan-24 6:00 AM View: | van Nostrand Robert L Director | Galena Biopharma, Inc. (SLS) | 22-Jan-24 | Grant | 6,000 | -- | -- | 136% 4.4K to 10.4K | |
| 25-Jan-24 6:01 AM View: | Varian John Director | Galena Biopharma, Inc. (SLS) | 22-Jan-24 | Grant | 6,000 | -- | -- | 136% 4.4K to 10.4K | |
| 25-Jan-24 6:02 AM View: | Wasman Jane Director | Galena Biopharma, Inc. (SLS) | 22-Jan-24 | Grant | 6,000 | -- | -- | 136% 4.4K to 10.4K | |
| 25-Jan-24 6:00 AM View: | Burns John Thomas CFO | Galena Biopharma, Inc. (SLS) | 22-Jan-24 | Grant | 47,000 | -- | -- | 86% 54.93K to 101.93K | |
| 08-Dec-23 4:10 PM View: | Burns John Thomas CFO | Galena Biopharma, Inc. (SLS) | 06-Dec-23 | Disposition (other) | 2,929 | $1.08 | $3,163.32 | (5%) 57.86K to 54.93K | |
| 08-Dec-23 4:11 PM View: | Wood Barbara A EVP, Gen. Counsel, Corp. Sec. | Galena Biopharma, Inc. (SLS) | 06-Dec-23 | Disposition (other) | 4,119 | $1.08 | $4,448.52 | (5%) 86.34K to 82.22K | |
| 08-Dec-23 4:10 PM View: | Francomano Robert Chief Commercial Officer | Galena Biopharma, Inc. (SLS) | 06-Dec-23 | Disposition (other) | 1,082 | $1.08 | $1,168.56 | (5%) 22.0K to 20.92K | |
| 08-Dec-23 4:10 PM View: | Stergiou Andelos M. President and CEO Director | Galena Biopharma, Inc. (SLS) | 06-Dec-23 | Disposition (other) | 12,268 | $1.08 | $13,249.40 | (5%) 229.69K to 217.42K | |
| 03-Feb-23 5:11 PM View: | van Nostrand Robert L Director | Galena Biopharma, Inc. (SLS) | 02-Feb-23 | Grant | 2,500 | -- | -- | 132% 1.9K to 4.4K | |
| 03-Feb-23 5:14 PM View: | Varian John Director | Galena Biopharma, Inc. (SLS) | 02-Feb-23 | Grant | 2,500 | -- | -- | 132% 1.9K to 4.4K | |
| 03-Feb-23 5:13 PM View: | Wasman Jane Director | Galena Biopharma, Inc. (SLS) | 02-Feb-23 | Grant | 2,500 | -- | -- | 132% 1.9K to 4.4K | |
| 03-Feb-23 5:18 PM View: | Wood Barbara A EVP, Gen. Counsel, Corp. Sec. | Galena Biopharma, Inc. (SLS) | 02-Feb-23 | Grant | 20,000 | -- | -- | 35% 56.34K to 76.34K | |
| 03-Feb-23 5:15 PM View: | Stergiou Andelos M. President and CEO Director | Galena Biopharma, Inc. (SLS) | 02-Feb-23 | Grant | 58,000 | -- | -- | 36% 161.69K to 219.69K | |
| 03-Feb-23 5:17 PM View: | Burns John Thomas CFO | Galena Biopharma, Inc. (SLS) | 02-Feb-23 | Grant | 20,000 | -- | -- | 68% 29.35K to 49.35K | |
| 03-Feb-23 5:11 PM View: | Scheinberg David A Director | Galena Biopharma, Inc. (SLS) | 02-Feb-23 | Grant | 2,500 | -- | -- | 120% 2.08K to 4.58K | |
| 03-Feb-23 5:14 PM View: | Francomano Robert Chief Commercial Officer | Galena Biopharma, Inc. (SLS) | 02-Feb-23 | Grant | 12,000 | -- | -- | 100% 0 to 12.0K | |
| 03-Feb-23 5:10 PM View: | Kalin Katherine Bach Director | Galena Biopharma, Inc. (SLS) | 02-Feb-23 | Grant | 2,500 | -- | -- | 100% 0 to 2.5K | |
| 05-Dec-22 4:13 PM View: | Burns John Thomas Senior VP, Finance & CAO | Galena Biopharma, Inc. (SLS) | 05-Dec-22 | Sale | 1,159 | $2.59 | $3,001.81 | (4%) 30.51K to 29.35K | |
| 05-Dec-22 4:12 PM View: | Wood Barbara A EVP, Gen. Counsel, Corp. Sec. | Galena Biopharma, Inc. (SLS) | 05-Dec-22 | Sale | 2,153 | $2.59 | $5,576.27 | (4%) 58.5K to 56.34K | |
| 05-Dec-22 4:14 PM View: | Stergiou Andelos M. President and CEO Director | Galena Biopharma, Inc. (SLS) | 05-Dec-22 | Sale | 6,494 | $2.61 | $16,938.30 | (4%) 168.18K to 161.69K | |
| 01-Feb-22 5:05 PM View: | Burns John Thomas Senior VP, Finance & CAO | Galena Biopharma, Inc. (SLS) | 31-Jan-22 | Grant | 9,600 | -- | -- | 54% 17.64K to 27.24K | |
| 01-Feb-22 5:05 PM View: | Scheinberg David A Director | Galena Biopharma, Inc. (SLS) | 31-Jan-22 | Grant | 1,900 | -- | -- | 1044% 0.18K to 2.08K | |
| 01-Feb-22 5:06 PM View: | Stergiou Andelos M. President and CEO Director | Galena Biopharma, Inc. (SLS) | 31-Jan-22 | Grant | 44,000 | -- | -- | 36% 121.17K to 165.17K | |
| 01-Feb-22 5:07 PM View: | Wood Barbara A EVP, Gen. Counsel, Corp. Sec. | Galena Biopharma, Inc. (SLS) | 31-Jan-22 | Grant | 13,000 | -- | -- | 31% 42.03K to 55.03K | |
| 01-Feb-22 5:06 PM View: | van Nostrand Robert L Director | Galena Biopharma, Inc. (SLS) | 31-Jan-22 | Grant | 1,900 | -- | -- | 100% 0 to 1.9K | |
| 01-Feb-22 5:06 PM View: | Varian John Director | Galena Biopharma, Inc. (SLS) | 31-Jan-22 | Grant | 1,900 | -- | -- | 100% 0 to 1.9K | |
| 01-Feb-22 5:07 PM View: | Wasman Jane Director | Galena Biopharma, Inc. (SLS) | 31-Jan-22 | Grant | 1,900 | -- | -- | 100% 0 to 1.9K | |
| 03-Dec-21 5:14 PM View: | Wood Barbara A EVP, Gen. Counsel, Corp. Sec. | Galena Biopharma, Inc. (SLS) | 02-Dec-21 | Sale | 847 | $6.25 | $5,297.73 | (2%) 42.88K to 42.03K | |
| 03-Dec-21 5:15 PM View: | Stergiou Andelos M. President and CEO Director | Galena Biopharma, Inc. (SLS) | 02-Dec-21 | Sale | 2,120 | $6.25 | $13,251.90 | (2%) 123.29K to 121.17K | |
| 03-Dec-21 5:13 PM View: | Burns John Thomas VP, Finance & Corp Controller | Galena Biopharma, Inc. (SLS) | 02-Dec-21 | Sale | 231 | $6.27 | $1,447.75 | (1%) 17.88K to 17.64K | |
| 08-Mar-21 4:26 PM View: | Stergiou Andelos M. President and CEO Director | Galena Biopharma, Inc. (SLS) | 04-Mar-21 | Grant | 19,750 | -- | -- | 25% 78.54K to 98.29K | |
| 08-Mar-21 4:51 PM View: | Wood Barbara A EVP, Gen. Counsel, Corp. Sec. | Galena Biopharma, Inc. (SLS) | 04-Mar-21 | Grant | 7,875 | -- | -- | 31% 25.0K to 32.88K | |
| 08-Mar-21 4:28 PM View: | Burns John Thomas VP, Finance & Corp Controller | Galena Biopharma, Inc. (SLS) | 04-Mar-21 | Grant | 2,875 | -- | -- | 29% 10.0K to 12.88K | |
| 16-Mar-20 9:17 PM View: | Burns John Thomas VP, Finance & Corp Controller | Galena Biopharma, Inc. (SLS) | 12-Mar-20 | Grant | 15,000 | -- | -- | 100% 0 to 15.0K | |
| 16-Mar-20 9:18 PM View: | Stergiou Andelos M. President and CEO Director | Galena Biopharma, Inc. (SLS) | 12-Mar-20 | Grant | 95,000 | -- | -- | 100% 0 to 95.0K | |
| 16-Mar-20 9:20 PM View: | Wood Barbara A EVP, Gen. Counsel, Corp. Sec. | Galena Biopharma, Inc. (SLS) | 12-Mar-20 | Grant | 35,000 | -- | -- | 100% 0 to 35.0K | |
| 03-Jan-19 9:03 PM View: | Stergiou Andelos M. President and CEO Director | Galena Biopharma, Inc. (SLS) | 31-Dec-18 | Market Sale | 23,277 | $1.25 | $29,189.40 | (5%) 450.13K to 426.86K | 71% |
| 26-Sep-18 7:43 PM View: | Lopez Fabio | Galena Biopharma, Inc. (SLS) | 24-Sep-18 | Disposition (other) | 2,523,990 | -- | -- | (100%) 2.52M to 0 | |
| 29-Dec-17 5:11 PM View: | Scheinberg David A Director | Galena Biopharma, Inc. (SLS) | 29-Dec-17 | Grant | 9,107 | -- | -- | 100% 0 to 9.11K | |
| 29-Dec-17 5:12 PM View: | Stergiou Andelos M. President and CEO Director | Galena Biopharma, Inc. (SLS) | 29-Dec-17 | Grant | 450,135 | -- | -- | 100% 0 to 450.13K | |
| 29-Dec-17 5:10 PM View: | Lopez Fabio Director 10% Owner | Galena Biopharma, Inc. (SLS) | 29-Dec-17 | Grant | 2,738,650 | -- | -- | 100% 0 to 2.74M | |
| 10-Oct-17 5:56 PM View: | Hillsberg Sanford Director | Galena Biopharma, Inc. (SLS) | 10-Oct-17 | Grant | 20,997 | $0.38 | $7,978.86 | 58% 35.95K to 56.95K | |
| 10-Oct-17 5:51 PM View: | Einhorn Irving M. Director | Galena Biopharma, Inc. (SLS) | 10-Oct-17 | Grant | 14,366 | $0.38 | $5,459.08 | 71% 20.32K to 34.69K | |
| 10-Oct-17 5:45 PM View: | Chin Richard Director | Galena Biopharma, Inc. (SLS) | 10-Oct-17 | Grant | 12,708 | $0.38 | $4,829.04 | 68% 18.63K to 31.34K | |
| 10-Oct-17 5:48 PM View: | Ashton William Director | Galena Biopharma, Inc. (SLS) | 10-Oct-17 | Grant | 15,472 | $0.38 | $5,879.36 | 68% 22.68K to 38.15K |
